Screening for the factor-V Arg 506 GIn mutation in patients with TIA and stroke

Cerebrovascular Diseases

Volumn 6, Issue 6, 1996, Pages 360-362

  Markus, Hugh S ^a   Zhang, Yufeng ^b   Jeffery, Steve ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Blood coagulation; Cerebrovascular disorders; Genetics; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; PRIORITY JOURNAL; RISK FACTOR; SCREENING; STROKE; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; VEIN THROMBOSIS;

EID: 0029827076     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000108053     Document Type: Article

References (10)

1. Brass LM, Issacsohn JL, Merikangas KR; Robinette CD: A study of twins and stroke. Stroke 1992;23:221-223.
2. Svensson PJ, Dahlbäck B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330:517-522.
3. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994,369:64-67.
4. Halbmayer WM, Haushofer A, Schon R, Fischer M: The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coagul Fibrinolysis 1994;5:51-57.
5. Simioni P, de Ronde H, Prandoni P, Saladini M, Bertina RM. Girolami A: Ischaemic stroke in young patients with activated protein C resistance. Stroke 1995;26:885-890.
6. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912-917.
7. Lalouschek W, Suess E, Aull S. Schnider P, Uhl F, Zeiler K, Pabinger-Fasching I: Clinical and laboratory data in heterozygous factor V Leiden mutation positive versus negative patients with TIA and minor stroke. Stroke 1995;26: 1963-1964.
8. Catto A, Carter A, Ireland H, Bayston TA, Philippou H, Barrett J, Lane DA, Grant PJ: Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vase Biol 1995;15:783-785.
9. Rees DC, Cox M, Clegg JB: World distribution of factor V Leiden. Lancet 1995:346:1133-1134.
10. Pullicino PM, Caplan LR, Hommel M (eds): Cerebral Small Artery Disease. New York, Raven Press, 1993.